Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

mindesta inc (MDST) Snapshot

Open
$0.04
Previous Close
$0.04
Day High
$0.04
Day Low
$0.04
52 Week High
09/23/14 - $0.15
52 Week Low
06/19/14 - $0.0040
Market Cap
7.5M
Average Volume 10 Days
4.2K
EPS TTM
$0.0017
Shares Outstanding
195.1M
EX-Date
--
P/E TM
22.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MINDESTA INC (MDST)

Related News

No related news articles were found.

mindesta inc (MDST) Related Businessweek News

No Related Businessweek News Found

mindesta inc (MDST) Details

Mindesta Inc. develops fast dissolving drug delivery systems for the pharmaceutical industry in Canada. Its technology platform develops advanced oral delivery thin wafers infused with natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. The company is headquartered in Ottawa, Canada.

mindesta inc (MDST) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mindesta inc (MDST) Key Developments

Mindesta Inc. Auditor Raises 'Going Concern' Doubt

Mindesta Inc. filed its 10-K on Apr 14, 2015 for the period ending Dec 31, 2014. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Mindesta Inc. announced delayed annual 10-K filing

On 03/27/2015, Mindesta Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Dr. Stephen Houldsworth, Pharma Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board

The Board of Directors of Mindesta Inc. announced the appointment of Dr. Stephen Houldsworth to it's advisory board of CTT Pharmaceuticals effective immediately.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDST:US $0.04 USD 0.00

MDST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDST.
View Industry Companies
 

Industry Analysis

MDST

Industry Average

Valuation MDST Industry Range
Price/Earnings 27.6x
Price/Sales -- Not Meaningful
Price/Book 12.8x
Price/Cash Flow 33.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MINDESTA INC, please visit www.cttpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.